Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03586999
Title Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors University of Colorado, Denver
Indications

anaplastic large cell lymphoma

peripheral T-cell lymphoma

angioimmunoblastic T-cell lymphoma

liver lymphoma

Therapies

Cyclophosphamide + Doxorubicin + Etoposide + Nivolumab + Prednisone + Vincristine Sulfate

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Cancer Center Duarte California 91010 United States Details
University of Colorado Hospital Aurora Colorado 80045 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field